| Log in

Shantha Biotechnics’ CEO on rebuilding vaccines business, products & strategy

14 October, 2014

Hyderabad-based vaccine maker Shantha Biotechnics was whacked four years ago after the World Health Organisation (WHO) cancelled its pre-qualified status and multi-million contract ....

To read the Full Story

Definitive news, exclusives, analyses and videos

  • Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
  • Daily, weekly and monthly curated newsletters on the deal ecosystem in India
  • Breaking news alerts
  • Participation in marquee events at concessional rates

Comprehensive | Accurate | Unbiased | Impeccably sourced


Leave Your Comment
Sanofi infusing $122M to complete buy-out of Shantha Biotech and further expansion

Sanofi infusing $122M to complete buy-out of Shantha Biotech and further expansion

Lohit Jagwani 4 years ago
Sanofi Aventis is investing Rs 755 crore to buy out the remaining minority...
Sanofi-Aventis Takes Control Of Shantha Biotechnics

Sanofi-Aventis Takes Control Of Shantha Biotechnics

TEAM VCC 8 years ago
French drug company Sanofi-Aventis said its vaccine unit Sanofi-Pasteur is...
Chartbusters: Top Five M&As of 2009

Chartbusters: Top Five M&As of 2009

TEAM VCC 8 years ago
This is what the M&A scorecard for 2009 looks like. The most talked about...
No Comments

Shantha Biotechnics’ CEO on rebuilding vaccines business, products & strategy

Powered by WordPress.com VIP